Future Applications of the Selective Prostacyclin (IP) Receptor Agonist Selexipag in Pediatric Pulmonary Hypertension
Crossref DOI link: https://doi.org/10.1007/s00246-017-1699-1
Published Online: 2017-08-07
Published Print: 2017-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Koestenberger, Martin
Hansmann, Georg
License valid from 2017-08-07